Draft HGC Insurance Press Release
HUMAN GENETICS COMMISSION RECOMMENDS MORATORIUM ON USE OF GENETIC TEST RESULTS
FOR LIFE INSURANCE
The Human Genetics Commission
today recommended to the Government that there should be an immediate moratorium
on the use of genetic test results by insurance companies for all classes of
insurance, and that this moratorium should be backed by legislation.
The moratorium should last for no less than three years, to allow time to
collect data that is not currently available and to consider adequately the
complex issues involved. It is essential to have a system that enjoys the
confidence of the public.
The HGC has been reviewing the wider social and ethical implications of the
use of genetic information in insurance at the request of Ministers. It has
reached its conclusions for four reasons:
The existing system of self-regulation has failed. As the House of
Commons Select Committee on Science and Technology recently observed,
insurance companies are not equally observing the Association of British
Insurers’ Code of Practice. There currently appears to be no satisfactory
means of monitoring and enforcing the code.
There is much disagreement and uncertainty about the interpretation of many
genetic tests. A clearer understanding of the possibilities and
limitations of genetic testing is likely to evolve over time.
The HGC believes that there needs to be effective regulation of this area.
Those who are affected by genetic conditions should not feel excluded from the
normal benefits of society, which, it might be argued, includes access to
insurance.
Public trust in genetic testing is essential. There is already evidence
that some people are put off taking genetic tests by the fear that they may be
seriously disadvantaged as a result. It is also important that public
participation in valuable genetic research is not jeopardised, and we welcome
the recent statements of the Association of British Insurers and others that
they would seek to avoid this outcome.
The insurance industry has expressed concerns that those who know that they
have a high genetic risk will deliberately buy large amounts of insurance. In
order to protect insurers from significant financial loss it is proposed that
very high value policies should not be covered by the moratorium. The HGC
suggest that this exception should apply to policies above £500,000. This
figure is arrived at on the basis of the industry’s own tables and
information.
Another exception should be made in those cases where an applicant for
insurance has a favourable genetic test result and the applicant chooses to
reveal this to a potential insurer.
The Next Step
The HGC hopes and intends in due course to recommend a future system. It is
important that it balances a number of interests including those of insurers,
insured persons, and the broader community. A variety of options is available,
ranging from a virtually complete ban on the use of genetic test results (as is
found in many European systems) to a properly enforceable system in which
limited use of certain results are allowed.
Priorities for further consideration include:
Identifying means of ensuring access to affordable insurance for those
affected by a genetic condition;
Considering wider regulatory and arbitration systems to ensure the
appropriate use of personal genetic information in insurance underwriting;
Initiating a debate on the wider role of private insurance in providing
access to social goods.
Examining the role of insurance in a reformed welfare state, particularly
with reference too issues such as long-term care.
The moratorium should not affect the current ability of insurance companies
to take into account favourable (i.e. negative) results of genetic tests or to
consider family history information. Family history is, of course, also genetic
information and during the proposed moratorium the HGC will also address how
such information is, and should be, handled by insurers in the future.
Baroness Helena Kennedy QC, Chair of the Human Genetics Commission, said:
"Our consultations have shown very real public concern on the issue of
genetics and insurance. On the basis of the evidence we have received, we have
profound misgivings about the industry’s handling of this information and its
ability to keep its own house in order. I hope that these proposals go some way
to reassure the public. They will also give the Commission the opportunity to
consult further and devise an enforceable system which can enjoy the confidence
of everyone.
Interim Recommendations of the HCG are here,
as a PDF
(portable document format)
file, which can be read using Adobe Acrobat Reader.
If you do not have this installed on your computer, to download and install
the program (which is available for Windows, Mac or Linux systems) at no cost,
click here:
